4/A: Strata Critical Medical Form 4 Amendment

Sentiment:

Form 4 Amendment


Scott M. Wunsch, CEO of Strata Critical Medical, Inc., filed an amendment to a prior Form 4 to correct a transaction code related to shares withheld for tax obligations.

Summary

  • This filing is an amendment to a previously filed Form 4 by Scott M. Wunsch, CEO of Strata Critical Medical, Inc.
  • The amendment corrects a transaction code used in Table I of the original Form 4.
  • The original filing incorrectly used the 'S' code for a disposal of Class A common stock on June 8, 2026.
  • The corrected transaction code is 'F', indicating shares were withheld by the Issuer to satisfy tax withholding obligations.
  • This withholding occurred in connection with a vesting event for restricted stock units.
  • The reporting person's beneficial ownership of 625,574 shares of Class A common stock remains unchanged, with 5,550 shares directly owned and 382,987 indirectly owned through a limited liability company.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a procedural amendment to correct a clerical error in a previous disclosure and does not introduce new financial or strategic information.

Positives

  • Correction of a filing error to ensure accurate reporting.
  • Confirmation that the underlying transaction (shares withheld for tax obligations) was properly approved and executed.
  • No change in the reporting person's overall beneficial ownership of Strata Critical Medical, Inc. stock.

Negatives

  • An initial error in filing the Form 4 required an amendment, indicating a procedural oversight.

Risks

  • Potential for minor scrutiny from the SEC due to the initial filing error, although it appears to be a clerical correction.
  • The need for amendments can sometimes raise questions about the thoroughness of internal compliance processes.

Future Outlook

This filing is an amendment to a previous Form 4 and does not contain forward-looking statements or guidance regarding the company's future financial performance or strategic direction.

Management Comments

  • The reporting person is hereby amending the Original Form to correctly show the 'F' code in Column 3 of Table I.
  • The information set forth in the Original Form was correct in all other respects.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insiders and amendments are common to correct clerical errors. This specific amendment relates to routine tax withholding upon vesting of equity awards, a common practice in the biotechnology and medical technology sectors where Strata Critical Medical operates.

Stakeholder Impact

  • Shareholders: The amendment provides clarity and accuracy to insider ownership reporting, reinforcing transparency.
  • Employees: The transaction relates to employee equity vesting and tax obligations, a standard aspect of compensation.
  • Management: Highlights the importance of meticulous compliance with SEC filing requirements.

Next Steps

  • Ensure all future SEC filings are accurate and adhere to reporting requirements.
  • Maintain accurate records of all insider transactions and related disclosures.

Key Dates

DateDescription
06/08/2026Date of the original transaction (disposal of shares withheld for tax obligations).
06/10/2026Date of the original Form 4 filing.
06/18/2026Date of the amended Form 4 filing.

Keywords

Form 4, SEC Filing, Strata Critical Medical, Scott M. Wunsch, Beneficial Ownership, Stock Withholding, Tax Obligations, Restricted Stock Units, CEO, Amendment

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.